Trials / Conditions / Hepatic Function Abnormal
Hepatic Function Abnormal
5 registered clinical trials studyying Hepatic Function Abnormal.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokineti NCT05718258 | Sanofi | Phase 1 |
| Completed | A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild NCT05607173 | Sanofi | Phase 1 |
| Completed | Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hep NCT05283915 | Sanofi | Phase 1 |
| Terminated | Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Norm NCT05126329 | Sanofi | Phase 1 |
| Completed | A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of NCT06444204 | Principia Biopharma, a Sanofi Company | Phase 1 |